NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Arlo Technologies, Inc. ARLO
Lead Plaintiff Deadline: March 25, 2019
Class Period: Investors who purchased shares pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the August 3, 2018 Initial Public Offering
Get additional information about ARLO: http://www.wongesq.com/pslra-1/arlo-technologies-inc-loss-submission-form?wire=3
VelocityShares Daily Inverse VIX Medium Term Exchange Traded Notes ZIV
Lead Plaintiff Deadline: April 5, 2019
Class Period: June 30, 2017 and February 5, 2018
Get additional information about ZIV: http://www.wongesq.com/pslra-1/velocityshares-daily-inverse-vix-medium-term-exchange-traded-notes-loss-submission-form?wire=3
Diplomat Pharmacy, Inc. DPLO
Lead Plaintiff Deadline: April 25, 2019
Class Period: February 26, 2018 and February 21, 2019
Get additional information about DPLO: http://www.wongesq.com/pslra-1/diplomat-pharmacy-inc-loss-submission-form?wire=3
Inogen, Inc. INGN
Lead Plaintiff Deadline: May 6, 2019
Class Period: November 8, 2017 and February 26, 2019
Get additional information about INGN: http://www.wongesq.com/pslra-1/inogen-inc-loss-submission-form?wire=3
To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.